CLRB
Cellectar Biosciences
$1.22
−$0.02 (−1.61%)Oct 29, 2026
Key metrics
The numbers that frame CLRB today
- Market cap
- $11.53M
- ROIC
- 1,353.3%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $1.12
- 52wk High
- $4.70
Growth
Revenue and earnings trend for CLRB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CLRB
Is Cellectar Biosciences a good buy?
No. Cellectar Biosciences has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of CLRB?
Cellectar Biosciences's market capitalization is $11.53M.
What is the 52-week high for CLRB stock?
The 52-week high for Cellectar Biosciences is $4.70. The current close of $1.22 is 74% below that high.
What is the 52-week low for CLRB stock?
The 52-week low for Cellectar Biosciences is $1.12. The current close of $1.22 is 8.9% above that low.
Does CLRB stock pay dividends?
Cellectar Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CLRB?
Cellectar Biosciences's Debt / Equity ratio is 0.05.